Creso Pharma begins revenue generation from Canadian cannabis sales

Company News

by Anna Napoli

Creso Pharma (ASX:CPH) is set to commence cannabis sales from its NovaScotia based facility.

The first dried flower sale is part of multi-year agreements that company has signed.

Creso Pharma expects to see revenue from the facility rising from the initial delivery invoice of Canadian $150,000 to more than Canadian $5 million by the end of 2019.

The company says it is now generating revenue in multiple markets with Canadian demand rapidly growing and the company well positioned to help meet this demand.

Shares in Creso Pharma (ASX:CPH) closed 4.76 per cent lower at $0.50 yesterday.